Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Fleming

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Endocrine-Related Cancer|July 12, 2014
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotideMatthew H Kulke, Thomas O'Dorisio, Alexandria Phan, et al.
Lancet (London, England)|August 11, 2015
An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trialPaul Little, Beth Stuart, F D R Hobbs, et al.
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid SyndromeMatthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
BMC Infectious Diseases|June 10, 2018
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014Saverio Caini, Peter Spreeuwenberg, Gabriela F Kusznierz, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Endocrine-Related Cancer|July 12, 2014
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotideMatthew H Kulke, Thomas O'Dorisio, Alexandria Phan, et al.
Lancet (London, England)|August 11, 2015
An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trialPaul Little, Beth Stuart, F D R Hobbs, et al.
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid SyndromeMatthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
BMC Infectious Diseases|June 10, 2018
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014Saverio Caini, Peter Spreeuwenberg, Gabriela F Kusznierz, et al.
Pageof 4